420 related articles for article (PubMed ID: 28820393)
21. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
[TBL] [Abstract][Full Text] [Related]
22. Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery.
Yuan X; Chen J; Cheng Q; Zhao Y; Zhang P; Shao X; Bi Y; Shi X; Ding Y; Sun X; Xue B
BMC Gastroenterol; 2018 Oct; 18(1):147. PubMed ID: 30285651
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.
Yilmaz Y; Yonal O; Kurt R; Alahdab YO; Eren F; Ozdogan O; Celikel CA; Imeryuz N; Kalayci C; Avsar E
Scand J Gastroenterol; 2011 Jan; 46(1):91-7. PubMed ID: 20809771
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
[TBL] [Abstract][Full Text] [Related]
25. Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis.
Emma MR; Giannitrapani L; Cabibi D; Porcasi R; Pantuso G; Augello G; Giglio RV; Re NL; Capitano AR; Montalto G; Soresi M; Cervello M
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158792. PubMed ID: 32777481
[TBL] [Abstract][Full Text] [Related]
26. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.
Arias-Loste MT; Iruzubieta P; Puente Á; Ramos D; Santa Cruz C; Estébanez Á; Llerena S; Alonso-Martín C; San Segundo D; Álvarez L; López Useros A; Fábrega E; López-Hoyos M; Crespo J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834919
[TBL] [Abstract][Full Text] [Related]
27. Low omentin-1 levels are related with clinical and metabolic parameters in obese children.
Catli G; Anik A; Abaci A; Kume T; Bober E
Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):595-600. PubMed ID: 24085389
[TBL] [Abstract][Full Text] [Related]
28. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
29. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.
Pohl R; Haberl EM; Rein-Fischboeck L; Zimny S; Neumann M; Aslanidis C; Schacherer D; Krautbauer S; Eisinger K; Weiss TS; Buechler C
Eur J Clin Invest; 2017 Jan; 47(1):7-18. PubMed ID: 27797398
[TBL] [Abstract][Full Text] [Related]
30. Changes in omentin levels and its mRNA expression in epicardial adipose tissue in patients undergoing elective cardiac surgery: the influence of type 2 diabetes and coronary heart disease.
Matloch Z; Kratochvílová H; Cinkajzlová A; Lipš M; Kopecký P; Pořízka M; Haluzíková D; Lindner J; Mráz M; Kloučková J; Lacinová Z; Haluzík M
Physiol Res; 2018 Dec; 67(6):881-890. PubMed ID: 30204471
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor 21 in non-alcoholic fatty liver disease.
Tucker B; Li H; Long X; Rye KA; Ong KL
Metabolism; 2019 Dec; 101():153994. PubMed ID: 31672443
[TBL] [Abstract][Full Text] [Related]
32. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.
Watanabe M; Risi R; Camajani E; Contini S; Persichetti A; Tuccinardi D; Ernesti I; Mariani S; Lubrano C; Genco A; Spera G; Gnessi L; Basciani S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708435
[TBL] [Abstract][Full Text] [Related]
33. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.
Dushay J; Chui PC; Gopalakrishnan GS; Varela-Rey M; Crawley M; Fisher FM; Badman MK; Martinez-Chantar ML; Maratos-Flier E
Gastroenterology; 2010 Aug; 139(2):456-63. PubMed ID: 20451522
[TBL] [Abstract][Full Text] [Related]
34. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
[TBL] [Abstract][Full Text] [Related]
35. Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity.
Siejka A; Jankiewicz-Wika J; Kołomecki K; Cywiński J; Piestrzeniewicz K; Swiętosławski J; Stępień H; Komorowski J
Cytokine; 2013 Nov; 64(2):490-3. PubMed ID: 24011638
[TBL] [Abstract][Full Text] [Related]
36. Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease.
Alisi A; Ceccarelli S; Panera N; Prono F; Petrini S; De Stefanis C; Pezzullo M; Tozzi A; Villani A; Bedogni G; Nobili V
PLoS One; 2013; 8(6):e67160. PubMed ID: 23840612
[TBL] [Abstract][Full Text] [Related]
37. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery.
Danin PE; Anty R; Patouraux S; Raucoules-Aimé M; Gugenheim J; Tran A; Gual P; Iannelli A
Obes Surg; 2018 Mar; 28(3):735-742. PubMed ID: 28875438
[TBL] [Abstract][Full Text] [Related]
38. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
39. YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity.
Wang L; Mazagova M; Pan C; Yang S; Brandl K; Liu J; Reilly SM; Wang Y; Miao Z; Loomba R; Lu N; Guo Q; Liu J; Yu RT; Downes M; Evans RM; Brenner DA; Saltiel AR; Beutler B; Schnabl B
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15184-15193. PubMed ID: 31289229
[TBL] [Abstract][Full Text] [Related]
40. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy.
Liu J; Xu Y; Hu Y; Wang G
Metabolism; 2015 Mar; 64(3):380-90. PubMed ID: 25516477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
